Blogs & News


Explore all that Huvepharma, Inc. has to offer!  Like us on Facebook and subscribe to our Youtube channel.

Huvepharma®, Inc. continues to grow with several new hires across multiple departments.

Peachtree City, GA (February 18th, 2022) – Huvepharma® is pleased to announce that Ed Bell, Tracy Harris Ⅲ, Doug Rupp and Dr. Doug Braun have joined the team since the beginning of the new year.

Huvepharma® Receives FDA Approval for Tilmovet® AC (tilmicosin phosphate)

Peachtree City, GA (February 9th, 2022) – Huvepharma® announces FDA approval for Tilmovet® AC (tilmicosin phosphate)

Huvepharma® announces Monovet® (monensin Type A medicated article) medicated feed combination approvals

The first FDA-approved generic monensin – available to U.S. beef, dairy, and goat producers as Monovet®90 (monensin Type A medicated article) from global animal health company Huvepharma®  – has now also received FDA approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.

FDA-approval granted to Huvepharma® for feed additive CycleGuard® 500 (melengestrol acetate Type A liquid...

PEACHTREE CITY, GA (June 24, 2020) — Huvepharma® has received FDA-approval for CycleGuard® 500 (melengestrol acetate).

1 2 3 5
1-4 of 19 results